Novel Anti-Inflammatory Flops for HFpEF, HFmrEF Phase II trial does hold a few signals that might warrant another attempt Nov 18, 2024
Gene Therapy Promising for Rare Genetic Cardiomyopathy Phase I results show "big improvement" for what is usually progressive hypertrophy, expert says Nov 18, 2024
AI Can Do Whole Echo Reports, Improve Efficiency AI transformation of the way cardiology uses echo "is absolutely going to happen, expert says Nov 17, 2024
Is DOAC a Viable Option After Bioprosthetic Valve Surgery Even in Sinus Rhythm? Japanese trial supports use but event risk might be low enough to suggest a different strategy Nov 17, 2024
Ablation Bests Drugs for Ventricular Tachycardia After Heart Attack VANISH2 trial may set new standard of care for ischemic cardiomyopathy patients Nov 16, 2024
Intensive Blood Pressure Control Benefits People With Type 2 Diabetes Too BPROAD trial replicates SPRINT trial findings in diabetes population in China Nov 16, 2024
Making the Alzheimer’s Disease Diagnosis History, symptoms, and cognitive tests form diagnostic backbone with imaging, biomarkers for some Nov 04, 2024
For Your Patients: The Stages of Alzheimer’s Disease The disease follows a predictable trajectory through mild, moderate, and severe symptoms Nov 04, 2024
Cardiac Arrest Drug Administration Route a Toss Up Two randomized trials compared intraosseous and intravenous routes for the initial access attempt Oct 31, 2024
SGLT2 Inhibitor Carry-Over Benefits Last How Long? Trial follow-up defines the need for long-term treatment in protecting the kidneys and heart Oct 29, 2024